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14 Tuning of physicochemical properties of ionic liquids and crystalline materials is a challenge that opens 
15 up unlimited possibilities for expanding applications and controlling biological activity of 
16 pharmaceutical multicomponent phases incorporating active pharmaceutical ingredients (APIs) with 
17 counterions or coformers. In this work we have investigated the effect of changing lidocaine (LID) and 
18 azelaic acid (AZE) ratios on the physicochemical properties of their corresponding multicomponent 
19 systems using a thermodynamics-based approach. Microscopy, X-ray diffraction analysis, infrared 
20 spectroscopy, nuclear magnetic resonance, and thermogravimetric analysis provided complimentary 
21 characterisation. Mechanochemical synthesis of LID:AZE systems at a range of stoichiometries yielded 
22 at least two distinct liquid phases and two distinct crystalline phases, one of which involved a unique 
23 2:3 LID:counterion composition not observed previously. Furthermore, to the best of our knowledge 
24 the formation of oligomeric ionic liquids involving dicarboxylic acids is also being reported for the first 
25 time. This work highlights the need for a careful characterisation of multicomponent systems, 
26 especially for pharmaceutical applications. 
27
28




33 A number of interesting works have been published very recently raising awareness on the 
34 continuum that exists between ionised and neutral pharmaceutical multicomponent systems.[1–3] A 
35 change in preparation methods, temperature or stoichiometry can modulate the ionic character of 
36 the system and yield different products as a result of complex interrelationship of kinetic and 
37 thermodynamic aspects.[1,4–6] In particular, there are examples illustrating that distinct crystalline 
38 structures obtained by varying stoichiometry of co-formers or counterions can tune the solid state 
39 properties and performance of an active pharmaceutical ingredient (API).[7–9] 
40 Although, the majority of the investigated pharmaceutically-relevant API multicomponent 
41 systems are crystalline the rising significance of low-melting point solids or even liquid forms of such 
42 systems has been recognised.[10–15] They include, but are not limited to ionic liquids, deep eutectic 
43 mixtures, ionic cocrystals and oligomeric ionic liquids. Until recently, the intermolecular interactions 
44 that play the major role in the classification of the liquid forms were mainly considered at simple 1:1 
45 stoichiometric ratios and stoichiometries dictated by the counterion of choice.[16,17] On the other 
46 hand, non-stoichiometric ratios were viewed as systems containing excess of either of the starting 
47 materials.[18] However, it has been shown that mixtures of the counterions or the co-formers at 
48 different stoichiometric ratios can potentially form distinct multicomponent systems not just in the 
49 solid but also in the liquid state.[2,19]
50 Our previous work concentrated on a range of API-ILs incorporating lidocaine and medium-
51 chain dicarboxylic acids as the counterions. [20] LID is an aminoamide drug used as a local anaesthetic 
52 with some antibacterial properties [21] and the molecule possesses one H-bond donor -NH group and 
53 3 H-bond acceptor groups (Scheme 1). LID is practically insoluble in water and is formulated as a salt 
54 to overcome the solubility constraints. The tertiary amine group has a pKa value of 7.9 rendering it a 
55 weak base and most of the known LID salts undergo ionisation at this site.[22,23] However, in an 
56 ionised form LID’s membrane permeability is severely impeded.[24] Careful co-former or counterion 
57 selection for a new LID multicomponent phase formation can greatly improve the API’s performance 
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58 without undergoing chemical modification.[14,25,26] The LID ionic liquids (ILs) based on medium-
59 chain dicarboxylic acids were evaluated in terms of their thermal and dynamic behaviour supported 
60 by crystallographic analysis in an attempt to devise a prediction tool for the structure–property 
61 relationship. Alternating trends in morphology, melting points, glass transition temperatures and 
62 crystallographic properties of the new phases were observed depending on the acid used. [20]
63 In this work we have investigated the influence of changing stoichiometry of LID and azelaic 
64 acid (AZE), another medium-chain dicarboxylic acid on the physicochemical properties of their 
65 corresponding multicomponent systems using a thermodynamics-based approach, which includes the 
66 construction of the solid-liquid binary phase diagrams. Microscopy, X-ray diffraction analysis, infrared 
67 spectroscopy, nuclear magnetic resonance, and thermogravimetric analysis provide complimentary 
68 characterisation. The molecular structures of LID and the dicarboxylic acid investigated in the study 
69 are shown in Scheme 1. AZE is a dicarboxylic acid commonly used as a topical bactericidal, antioxidant 
70 and anti-inflammatory agent.[27–29] AZE is a weak acid with 2 carboxylic acid moieties at both ends 
71 of the alkyl chain with pKa values of 4.550 and 5.498. The differences in pKa values (i.e. ΔpKa = pKa(base) 
72 – pKa(acid) are 3.35 and 2.4 meaning that both, salts and cocrystals could potentially be formed.[30]
73 Other known LID:dicarboxylic acid multicomponent systems reported to date were solely ionized 
74 systems.[20,23,31] It was thus hypothesised that the LID:AZE combination would yield a similar 
75 LID:dicarboxylic acid system. However, mechanochemical synthesis of LID:AZE systems yielded at least 
76 two distinct liquid phases and two distinct solid phases, one of which involved a unique 2:3 
77 LID:counterion composition not observed previously. Furthermore, to the best of our knowledge the 
78 formation of oligomeric ionic liquids involving dicarboxylic acids have been reported for the first time. 
79 2. Materials and Methods
80 2.1 Materials
81 LID (as a base) and azelaic acid (AZE) were purchased from Sigma-Aldrich (Ireland). Potassium 
82 bromide for Infrared analysis was obtained from Honeywell Fluka and was dried in a vacuum oven at 
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83 room temperature prior to use. The purity of the compounds was at least 98%. All compounds were 
84 used as obtained. Absolute ethanol used was of HPLC grade (Fisher Scientific, UK).
85 2.2 Methods
86 2.2.1 Sample preparation
87 LID and AZE was processed at a range of molar fractions between 0.1:0.9 to 0.9:0.1 (LID:AZE). 
88 The constituents were accurately weighted with a Mettler Toledo MT5 microbalance (Mettler Toledo, 
89 Switzerland) and ground in an agate mortar and pestle until homogenous mixtures were obtained. A 
90 total of 200 mg of each sample was produced. A sample of each mixture was immediately analysed 
91 and the remaining mixtures were transferred to 2 mL microcentrifuge tubes and kept at 4 °C until 
92 further analysis. 
93 2.2.2 Polarised Optical Microscopy
94 Prior to analysis LID and AZE were recrystallised from ethanol. A small crystal of each, LID and 
95 AZE, were placed on a glass slide and were pushed together with the help of a needle. The glass slide 
96 was examined using Olympus BX53 polarising optical microscope (Ireland) equipped with a U-POT 
97 cross polarizer and a U-ANT analyser. Images were taken with an integrated Q IMAGING Fast 1394 
98 camera (Olympus, Japan). The experiment was performed at room temperature.[20]  
99 2.2.3 Thermogravimetric Analysis (TGA)
100 TGA was performed using Mettler TG50 measuring module coupled to a Mettler Toledo MT5 
101 balance (Switzerland). Samples were weighed into an open aluminium pan (sample size approximately 
102 5-11 mg) and heated from 25 °C to 200 °C at a rate of 10 K min-1 under nitrogen as a purge gas. Upon
103 completion the samples were visually inspected and the thermograms were analysed for degradation 
104 using Mettler Toledo STARe software (version 6.10). 
105 2.2.4 Differential Scanning Calorimetry (DSC)
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106 DSC measurements were carried out using a PerkinElmer Pyris1 Diamond DSC unit (USA). The 
107 unit was refrigerated using a ULSP B.V. 130 cooling system (Netherlands). [20,32] Approximately 3-6 
108 mg samples were weighed into aluminium pans and sealed. The samples were heated from 25 °C to 
109 115 °C at the rate of 10 K min-1 with nitrogen at a flow rate of 40 mL min-1 used as the purge gas. The 
110 samples were then supercooled to -60 °C at 300 K min-1 cooling rate and a second heating cycle was 
111 performed. Thermograms were analysed using Perkin Elmer Pyris software.
112 2.2.5 Fourier-Transform Infrared (FTIR) analysis
113 Prior to analysis LID:AZE mixtures at selected compositions were heated at 60 °C under 
114 nitrogen gas for 30 min to remove moisture. The samples were prepared as KBr disks using direct 
115 compression using a hydraulic press. Sample loading was approximately 1% (w/w). Infrared spectra 
116 were recorded on Spectrum One spectrometer (Perkin Elmer, USA). A spectral range of 650-4000 cm-1 
117 and accumulation of 8 scans were used. Spectra was analysed using Spectrum v. 5.0.1 software.
118 2.2.6 Powder X-ray Diffraction (PXRD) analysis
119 The LID:AZE samples were prepared at room temperature and were kept at 4 °C prior to 
120 analysis. PXRD was carried out at room temperature using Rigaku Miniflex II X-ray diffractometer 
121 (Japan) equipped with Cu Kα radiation (1.54 Å) X-ray source. The samples were scanned over a 2θ 
122 degrees range of 2–40° with a scan rate of 0.05 °/s. The tube voltage and tube current used were 30 kV 
123 and 15 mA, respectively. [20]
124 2.2.7 Single Crystal X-ray Diffraction (SXRD)
125 Preparation of Phase 1 (2:1 LID:AZE cocrystal) - A sample of LID:AZE at equimolar composition 
126 was heated until freely flowing liquid was obtained. The liquid sample was poured inside an NMR tube 
127 and was kept in the fridge until crystals were observed. 
128 Preparation of Phase 2 (2:3 LID:AZE ionic liquid) - Solidified polycrystalline powder at 1:1 molar 
129 composition was obtained upon prolonged storage for 6 months at room temperature. A few crystals 
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130 were removed with a needle to be seeded onto a drop of liquefied 1:2 LID:AZE mixture on a glass slide 
131 and kept at room temperature. Larger crystals of satisfactory quality for SXRD analysis were harvested 
132 after a week. 
133 Data for 2:1 LID:AZE cocrystal and 2:3 LID:AZE salt samples were collected on a Bruker Apex 
134 Kappa Duo using Cu Kα radiation (λ = 1.54178 Å) using a MiTeGen microloop and at 100(2) K (Oxford 
135 Cobra Cryosystem). Bruker APEX [33] software was used to collect, correct (Lorentz and polarization) 
136 and reduce data. Absorption corrections were applied using SADABS.[34] The structure was solved 
137 with the SHELXT [35] structure solution program using Intrinsic Phasing and refined with the SHELXL 
138 [36] refinement package using Least Squares minimisation with Olex2[37], using the space group P21,
139 with Z = 2 for the formula unit, C37H60N4O6. Details of the data and refinement are given in Table S1. 
140 All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were assigned to calculated 
141 positions using a riding model with appropriately fixed isotropic thermal parameters; donor hydrogen 
142 atoms (H9a, H9b, 18, H30) were located and refined with restraints (DFIX). The absolute configuration 
143 was determined and confirmed by refining the Flack parameter as 0.3(2). CCDC 2098381 (Phase 1) and 
144 2098382 (Phase 2) contain the supplementary crystallographic data for this paper. The data can be 
145 obtained free of charge from The Cambridge Crystallographic Data Centre via 
146 www.ccdc.cam.ac.uk/structures. The pXRD and SXRD were compared using EXPO2014 [38] with a final 
147 Le Bail refinement using the Pearson VII peak shape function with a w= 1.0/count weighting scheme. 
148 Final agreement factors, 2:1 LID:AZE cocrystal : Rp = 10.017, Rwp = 14.605, Re = 4.926 and Chi2 = 
149 8.791; 2:3 LID:AZE salt : Rp = 7.525, Rwp = 10.284, Re = 6.203, Chi2= 2.748.
150 2.2.8 Proton Nuclear Magnetic Resonance (1H-NMR)
151 Crystalline 1:1 LID:AZE sample obtained upon prolonged storage at room temperature and 2:1 
152 LID:AZE sample freshly prepared by neat grinding were dissolved in DMSO-d6. 1H-NMR measurements 
153 were performed using Bruker Avance III 400 MHz spectrometer. The NMR spectra were analysed using 
154 TopSpin 4.0.9 software. See SI and Figure S1 for the 1H-NMR peak assignment. 
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155 3. Results and discussion
156 3.1 Morphology of samples
157 The study was initiated by solvent-free neat grinding mechanochemical synthesis of the 
158 LID:AZE systems at 0.1:0.9 – 0.9:0.1 molar compositions. Samples in the χLID = 0.33 to 0.66 range 
159 yielded semiliquid or soft solid (paste) samples at room temperature (Figure 1a). On the contrary, 
160 systems at extreme molar LID or AZE molar fractions were solid powders. POM analysis was performed 
161 to visually examine the process of liquefaction. The POM images in Figure 1b display the solid fusion 
162 experiment where recrystallised LID and AZE were placed side by side and solid state reactivity was 
163 observed. Crystalline regions that were in a direct contact started undergoing liquefaction at room 
164 temperature almost immediately and a noticeable change was observed at t = 10 min. At t = 7 days 
165 the entire interface has liquefied. This observation indicates that the melting point of the product of 
166 the solid-state reaction is below room temperature and such behaviour is characteristic of a liquid, or 
167 a “deep”, eutectic formation.[20,39,40] The remaining crystalline material that was not in a direct 
168 contact has not been altered signifying the liquid eutectic does not diffuse nor dissolve parent 
169 materials further. POM image in Figure 1c obtained at t = 14 days displays the formation of new 
170 dendritic structures. These structures may suggest an irregular eutectic morphology of this phase 
171 and/or a new phase formation.[41] Previously, POM demonstrated that LID reacted with glutaric acid 
172 or pimelic acid showed a similar behaviour and these LID:dicarboxylic acid mixtures underwent solid 
173 interdiffusion, while LID and suberic acid displayed true solid-state reactivity with the formation of a 
174 solid eutectic at the interface. [20]
175 3.2 Thermal analysis
176 Starting materials LID and AZE as well as their mixtures at three different molar compositions 
177 (2:1, 1:1 and 21:21 LID:AZE) were analysed for thermal degradation by TGA (Figure 2a). The results 
178 showed that the weight loss upon heating up to 120 °C did not exceed 2%, see Figure 2b and cb. 
179 Heating of the materials up to 120 °C generally results in dehydration or solvent evaporation. A very 
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180 slight increase in weight loss exhibited by the binary mixtures might be associated with increased 
181 hygroscopicity of the samples following mixing. This observation is not unusual as it has been shown 
182 that low melting systems generally display elevated hygroscopicity.[13] On the other hand, upon 
183 heating to 200 °C the % weight loss is mainly caused by sample degradation. In this case LID and 2:1 
184 LID:AZE underwent extensive degradation. However, upon addition of increased amount of AZE the 
185 degradation was decreased. These results are also illustrated by the sample colour change after the 
186 analysis. As seen in Figure 2a 2:1 LID:AZE mixture turned very dark brown as compared to lighter 
187 brown colours of 1:1 and 1:2 samples. 
188 DSC analysis of freshly prepared samples was carried out to study the phase change behaviour 
189 of the LID:AZE systems at various molar compositions. Figure 3a presents a stack of DSC thermograms 
190 of the first heating cycle at different LID:AZE molar compositions. LID and AZE exhibit sharp 
191 endothermic peaks corresponding to their melting points of 69 °C and 106 °C, respectively. The 
192 melting point depression of LID is observed and is indicated by a blue arrow as increasing molar 
193 concentrations of AZE are added to the binary mixtures. A similar melting point depression is observed 
194 in AZE (indicated by a brown arrow) with increasing LID content. This observation follows simple binary 
195 phase behaviour as a result of decreasing purity of the starting components and has been observed in 
196 numerous multicomponent systems previously.[42,43] In addition to the endothermic peaks 
197 corresponding to the fusion events of the starting components the presence of new endothermic 
198 peaks in LID:AZE mixtures indicates the formation of new crystalline arrangements. As visible from the 
199 endothermic peaks in the yellow box the mechanochemical grinding of LID and AZE at high LID molar 
200 concentrations leads to a new phase formation, referred to as Phase 1. At χLID = 0.6 and 0.55 a melting 
201 point depression of this Phase 1 is observed. The evolution of a double peak unique to 1:1 molar 
202 composition infers the coexistence of two distinct crystalline arrangements. However, the second 
203 peak is not easily discerned in samples with higher AZE content, probably due to the creation of 
204 additional hydrogen bonds between the new crystalline structure and free diacid which leads to 
205 further sample liquefication. This phenomenon has been described previously in the formation of 
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206 deep eutectic mixtures (DEMs) and oligomeric ionic liquids.[44,45] It has been shown, but not 
207 generally recognised, that other forms of ionic liquids and DEMs can form at non-stoichiometric 
208 compositions and it is not just a 1:1 ionic liquid with excess carboxylic acid.[19,46–48] It has been 
209 proposed that such arrangement in the liquid phase can be described as [BH+][(RCOO)2H-].[18] The 
210 inherent slow crystallisation kinetics of these systems hinders phase identification. In an attempt to 
211 curtail liquefaction samples in the range of χLID = 0.9 to 0.2 were prepared and stored in the fridge for 
212 1 day prior to analysis. As indicated by a red box and arrow in Figure 3b, this sample treatment method 
213 enhanced new phase crystallisation, referred to as Phase 2.
214 Experimental Tm values were plotted as a function of LID molar fraction as seen in Figure 4. 
215 Dashed lines represent theoretical Schroeder van Laar solubility curves calculated using Equation 1, 
216 where Tfus (K) denotes the temperature of fusion and  ΔHfus (J mol−1)  denotes the enthalpy of fusion of 
217 the pure starting component, χ is the mole fraction of the pure starting component at a specified 
218 temperature T (K), and R is the gas constant.
219 (Eq. 1)𝑇 = ( 1𝑇𝑓𝑢𝑠 ―  𝑅ln χ ∆𝐻𝑓𝑢𝑠)
220 It is evident that the melting points of the parent components can be reasonably predicted at their 
221 corresponding extreme molar fractions. This agreement suggests that the unreacted starting 
222 components remain in the mixture in their unchanged form and no additional intermolecular 
223 interactions are depressing their corresponding Tm. However, the Tm of the parent components 
224 disappear at 0.3:0.7 – 0.6:0.4 LID:AZE molar compositions. This region is highlighted in Figure 4. This 
225 observation suggests new intermolecular interactions being created within the system and is 
226 corroborated by the appearance of melting events of Phase 1 and Phase 2. It is interesting to note that 
227 at the equimolar composition the melting events of the these phases merge, thus creating a sensitive 
228 equilibrium where the identity of phase formation depends on fine sample preparation and storage 
229 variables. 
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230 Upon completion of the first heating step the samples at the entire range of compositions 
231 were fast cooled at a nominal rate of 300 K/min and then subjected to a second heating step. Figure 
232 S2 presents a stack of second heating DSC thermograms which reveal the presence of glass transition 
233 events (Tg) in LID:AZE mixtures which implies the ability of the systems to be supercooled. Pure starting 
234 components do not exhibit Tg transitions as they crystallise during the cooling step. It is important to 
235 note that the samples at the extreme LID and AZE compositions also undergo partial crystallisation 
236 upon cooling and the Tg values of these systems are indicated by open star symbols in Figure 4. As can 
237 be seen from Figure 4, there is a clear maximum in Tg at the equimolar composition of the acid and 
238 the base. The observed extremum in Tg behaviour can be explained in terms of ionicity degree. 
239 Previously, a marked increase in Tg has been correlated with the conversion of a given API into its 
240 corresponding salt form e.g. hydrochloride, sulphate or phosphate.[44,49] Moreover, it has been 
241 established that an increase in the Tg and melting point of classical aprotic ionic liquids is observed 
242 when the electrostatic interactions start to dominate van der Waals forces.[50] Consequently, it is 
243 expected that the supercooled equimolar LID:AZE system exhibits the most efficient proton transfer 
244 and thus, comprises the highest concentration of ionised species.
245 3.3 Investigation of ionicity in the supercooled state
246 FTIR spectroscopy was employed to investigate the changes in intermolecular interactions 
247 within the liquid systems as a function of LID:AZE molar composition (Figure 5a) to corroborate the 
248 results obtained by thermal analysis. The systems were melted and analysed by FTIR immediately to 
249 mimic the supercooled state investigated by the second DSC heating cycle. The clear Tg maximum 
250 observed at the equimolar LID:AZE composition suggests the highest degree of ionisation and thus, 
251 ionic liquid formation. One of the most prominent peaks observed corresponds to the carbonyl 
252 stretching vibration and appears at 1664 cm-1 and 1694 cm-1 in LID and AZE spectra, respectively. The 
253 magnified carbonyl region is presented as an inset in Figure 5b for clearer visualisation. However, 
254 spectra obtained for the binary LID:AZE mixtures exhibit an additional carbonyl signal not attributable 
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255 to parent materials. This phenomenon is most clearly visible in the mixtures with higher LID content. 
256 In the 2:1 LID:AZE supercooled sample the signal is found at 1717 cm-1 and its position is shifted to 
257 1724 cm-1 in 1:1 supercooled LID:AZE mixture. In χLID = 0.4 mixture the peak appears as a shoulder at 
258 around 1717 cm-1. The emergence of this peak may imply the formation of intermolecular H-bonds 
259 between the -NH moiety of the LID’s amide group and the carbonyl group of the AZE. As a result of -
260 NH group participating in the creation the new H-bond, the C=O bond is strengthened and a shift to 
261 higher wavenumbers is observed. The greatest shift at the 1:1 composition suggests the strongest 
262 amide-carbonyl H-bond formation, most probably due to formation of the homogenous 1:1 molecular 
263 arrangement. This reasoning is corroborated by the complete disappearance of pure LID signal as a 
264 result of being entirely used up in the 1:1 complex formation. Hence, giving rise to the observed Tg 
265 maximum. On the other hand, AZE C=O signal persists in the spectrum, which can be explained by the 
266 availability of 2 carbonyl groups and 1 being left unchanged. In addition, a prominent symmetric 
267 stretching carboxylate ion peak at 1540 cm-1 appears in the spectra of mixtures, which provides an 
268 indication that ionisation in the form of proton transfer between LID and AZE has taken place. 
269 The decreased intensity and wavenumber of the amide N-H stretch at 3250 - 3170 cm-1 region 
270 is caused by the dilution of LID in AZE and the formation of the H-bond (vide supra). A peak assignment 
271 table is presented in Table S2. The presence of proton transfer in the 1:1 complex implies the 
272 formation of an ionic liquid. The systems with the higher acid content, i.e. in the range χLID = 0.4 to 
273 0.33 possess a greater number of hydrogen bonds formed within the complexes and, as a result, the 
274 systems are further liquefied. Depending on the arrangement of these additional H-bonds formed the 
275 compositions may be classified as either oligomeric ionic liquids or deep eutectic mixtures. 
276 3.4 Investigation of crystalline phases
277 PXRD analysis of the samples prepared as described in Section 2.2.1 revealed the formation 
278 of a new crystalline phase at χLID = 0.5 to 0.2 range of compositions, as seen in Figure 6. Melting of this 
279 this new system, Phase 2, was first observed by thermal analysis (Figure 4). The PXRD pattern 
280 corresponding to the new phase displays peaks that do not appear in the patterns on the parent 
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281 materials, such as at 2θ = 6°, 11°, 14° and 16°. Low intensities of the peaks were observed due to the 
282 sample being partially liquid. A peak at 2θ = 6° appears at a lower position as compared to the first 
283 peaks of the parent materials signifying the formation of a larger crystal lattice. 
284 An attempt to obtain a single crystal of Phase 2 has unexpectedly resulted in an identification 
285 of a second, new crystalline phase, Phase 1. The PXRD pattern of this system is highlighted in red 
286 colour in Figure 6 and appears to be very similar to pure LID with some differences. In particular, the 
287 2:1 system displays a peak at 2θ = 8.4° as compared to a peak at 2θ = 8.2° seen in LID, and displays 
288 unique peaks at 2θ = 11°, 18°, 24°, 27° and 28°. These peaks are also visible in the pattern of the χLID 
289 = 0.5 mixture implying sample heterogeneity, where both new crystalline products coexist in 
290 equilibrium. 
291 3.5 Effects of sample preparation and storage on systems speciation 
292 It is important to note the impact of method of sample preparation and storage conditions on 
293 the LID:AZE complex formation. DSC analysis was performed using freshly ground samples without 
294 preheating in order to capture any thermal transitions that occur at lower temperatures. For example, 
295 a freshly ground 1:1 LID:AZE sample appears as a liquid (Figure 1a) with a small amount of solid 
296 particles suspended within the liquid matrix. These particles were later identified as nucleation sites 
297 for the formation of the new crystalline complexes (Phase 2) and DSC thermograms of these samples 
298 allowed to capture their melting points. However, preheating 1:1 LID:AZE samples up to 60 °C in an 
299 oven destroyed these crystallisation nucleation sites resulting in a stable for at least 6 months ionic 
300 liquid that did not crystallise on storage at room temperature. PXRD analysis of the freshly ground 
301 samples allowed identification of the new crystalline structures being formed from these nucleation 
302 sites, these crystals showed distinct PXRD patterns as seen in Figure 6. PXRD analysis of the equimolar 
303 sample performed after preheating did not display any diffraction peaks and resulted in a disordered 
304 “halo”. The samples with the higher AZE content exhibited analogous behaviour. Therefore, it is 
14
305 possible to conclude that LID:AZE molten mixtures form distinct ionic liquid phases at a range of 
306 equimolar and non-stoichiometric ratios with greater acid content. 
307 On the other hand, the base-rich 2:1 LID:AZE mixture was not as sensitive to environmental 
308 variables. Crystalline Phase 2 was successfully obtained by both methods, neat grinding at room 
309 temperature and co-melting parent components in an oven. Another important observation to note 
310 is the equilibrium of the 2:1 and 1:1 complex formation in the LID:AZE equimolar mixtures. Depending 
311 on the preparation and storage conditions different crystalline phases were observed and the 
312 summary of the observations in presented in Table 1. The bulk synthesis of Phase 2 was not successful. 
313 A range of seeding experiments were also attempted, where a polycrystalline impure Phase 2 was 
314 seeded in a molten equimolar LID:AZE mixture, in a molten 1:2 LID:AZE mixture and in multiple organic 
315 solvents. The impure Phase 2 contained a mixture of crystalline LID and both of the crystalline systems. 
316 As a result, in most cases an identical impure polycrystalline material was obtained. These results can 
317 be explained by the differences in the stability and solubility exhibited by these complexes, where the 
318 least soluble and most stable system crystallising out first. This phenomenon has been identified and 
319 investigated in other binary systems with LID [51] and other APIs [1,52,53]. However, seeding in a 
320 molten acid-rich 1:2 mixture yielded a pure Phase 1 crystal with quality satisfactory for SXRD analysis. 
321 The crystallisation work performed with LID:AZE mixtures was very challenging and before single 
322 crystals were obtained a suspicion was raised that one of the crystalline phases might actually be a 
323 degradation product. To check for sample degradation 1H-NMR analysis was performed. The peak 
324 assignment presented in Figure S1 indicates that Phase 1 and Phase 2 differ in the solid state, but 
325 degradation products were not observed in the 1H-NMR spectra.
326 3.6 Single Crystal XRD analysis
327 Single crystals of the two distinct crystalline phases, Phase 1 and Phase 2,  were obtained and 
328 analysed. Phase 1, the 2:1 LID:AZE complex with a melting point of 47 °C and crystallising in a 
329 monoclinic P21 space group was identified as a cocrystal. The theoretical PXRD pattern generated from 
330 the SXRD data closely matched experimental PXRD patterns by visual inspection and a Le Bail 
15
331 refinement with difference pattern shown in Figure S3. The asymmetric unit contains 2 LID molecules 
332 and 1 AZE molecule held together by H-bonding interactions as seen in Figure 7a. The strongest H-
333 bonds are formed between the LID tertiary amine moiety and both AZE carboxylic groups with d(D...A) 
334 = 2.583(3) and 2.603(3) Å. The formation of a cocrystal, rather than a salt is also evidenced by the AZE 
335 carboxylic C-O bond length analysis. In salts, the deprotonation of a carboxylic acid results in a 
336 carboxylate ion possessing two C-O bonds with similar DC-O, i.e. the ∆DC-O < 0.03 Å, where ∆DC-O is the 
337 difference in length between the two C-O bonds within a carboxylate moiety. In cocrystals, neutral 
338 carboxylic acids would possess two distinct C-O bonds with ∆DC-O > 0.08 Å.[54] The 2:1 LID:AZE complex 
339 exhibits high ∆DC-O values of 0.119 and 0.125 Å confirming cocrystal formation. The crystal structure is 
340 further stabilised by the hydrogen-bonded NH…O heterosynthons (d(D…A) = 2.900(3) and 2.932(3) Å) 
341 formed between the LID amide moieties and further weak CH…O interactions (d(D…A) = 3.243(3) Å). 
342 The resulting structure forms zig-zag crystallisation patterns as seen in Figure 7b. See Figure S5 and 
343 Table S3 for atom labels and a list of all hydrogen bonds present within the system.
344 Interestingly, despite the fact that the crystalline 2:1 LID:AZE system is a cocrystal, FTIR 
345 analysis showed that the carboxylate ion peak was also visible in the supercooled mixture of the same 
346 composition (Figure 5). This is due to the ability of the system to be partially liquified as indicated by 
347 the presence of a Tg transition observed by DSC (Figure 4). Hence, the supercooled fraction of the 
348 sample exhibits proton transfer due to increased molecular mobility.  
349 The second crystalline phase, Phase 2, comprises a highly unusual 2:3 LID:AZE ratio and it is 
350 characterised by a melting point onset of 50 °C. No other crystalline structures involving LID at such 
351 ratio with other counterions or co-formers has been deposited in the CSD database to date. The 
352 complex crystallises in a triclinic P  space group with 2 LID and 3 AZE molecules constituting an 1
353 asymmetric unit. Theoretical PXRD patterns generated from the SXRD data closely match 
354 experimental PXRD patterns by visual inspection and a Le Bail refinement with difference pattern 
355 shown in Figure S4. The crystalline structure is composed of 2 unionised AZE molecules, 1 doubly 
16
356 ionised AZE anion and 2 ionised LID cations which are held together via a complex network of 
357 hydrogen bonding interactions as seen in Figure 8a-b. The 2 LID molecules are ionised at the tertiary 
358 amine sites via a proton transfer from both carboxyl moieties of a single AZE molecule. The complete 
359 deprotonation of AZE is supported by C-O bond analysis, where the two carboxyl moieties possess 
360 ∆DC-O of 0.004 and 0.006 Å. The deprotonated carboxylate anions form hydrogen bonding interactions 
361 with LIDH+ cations via all possible amine and amide H-bond donors, the strongest of which occurs 
362 between the carboxylate anion and an amide moiety COO-…NH with d(D…A)= 2.811(6) Å. The doubly 
363 deprotonated AZE anion is further stabilised by H-bonds arising from unionised AZE carboxyl donors 
364 with d(D…A) distances ranging from 2.559(6) to 2.633(6) Å. See Figure S6 and Table S4 for atom labels 
365 and a list of all hydrogen bonds present within the system. The structure is highly complex which 
366 explains the great difficulty faced during crystallisation efforts. 
367 The molecular arrangement resembles the bonding pattern characteristic of oligomeric ionic 
368 liquids. However, all oligomeric ILs reported to date are formed from monocarboxylic acids and the 
369 generalised molecular formula is generally accepted as [BH+][(RCOO)2H-].[18] The LID:AZE complex 
370 presented in this paper is the first example of oligomeric ionic liquid composed of anions derived from 
371 dicarboxylic acids. The molecular formula of the crystalline oligomeric complex may be written as 
372 [(BH+)2][(HOOCRCOOH)2(OOCRCOO)2-].   Due to the presence of a greater number of H-bonding donors 
373 and resultant increased complexity of the potential ion patterns the molecular formula characterising 
374 this crystalline complex may or may not be applicable to other dimeric or higher order oligomeric 
375 anions and ionic liquids. It is also important to note that the crystalline structure corroborates the 
376 interactions in the solid state and these findings support the presence of analogous interactions in the 
377 liquid phase. Therefore, the 2:3 crystalline salt is the equivalent solid structure to the 2:3 oligomeric 
378 ionic liquid in the liquid phase. In this context, the molecular formula of the 1:2 LID:AZE oligomeric 
379 ionic liquid is [BH+][(HOOCRCOO)2H-].
380 4. Conclusions
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381 This work has highlighted the importance of considering a range of stoichiometric ratios for 
382 the formation of multicomponent systems incorporating acid-base pairs. Despite a series of equimolar 
383 LID:dicarboxylic acid salts published previously we have demonstrated that LID and AZE binary 
384 mixtures at various molar compositions can form a range of distinct multicomponent phases. This 
385 approach allows for fine-tuning of physicochemical and crystallisation properties of a binary system 
386 without altering its constituents. Neat grinding of LID and AZE has resulted in the formation of liquid 
387 or semiliquid systems at the χLID = 0.33 to 0.66 molar fractions, where 1:1 composition exhibited the 
388 highest ionicity attributable to an ionic liquid formation. The greatest extent of liquefaction at χLID = 
389 0.4 was attributed to an oligomeric ionic formation, the crystal structure of which was solved to be a 
390 2:3 oligomeric crystalline ionic liquid. To the best of our knowledge, such system is the first example 
391 of an oligomeric ionic liquid composed of anions derived from dicarboxylic acids with a 
392 [(BH+)2][(HOOCRCOOH)2(OOCRCOO)2-] general molecular formula. In addition, a crystal structure of 
393 2:1 LID:AZE cocrystal was also successfully obtained. These results suggest that prediction of acid-base 
394 multicomponent systems formation is more challenging when variable stoichiometric ratios are 
395 considered. However, addressing the non-stoichiometric approach allows for a better understanding, 
396 modification and visualisation of alternative forms of multicomponent phases. 
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561 Scheme 1. Molecular structures of LID (left) and AZE (right). Yellow- H-bond donor and acceptor; blue- 
562 H-bond acceptor; red- carboxylic acid groups. 
563
564 Table 1. Impact of preparation and storage variables on phase crystallisation in equimolar LID:AZE 
565 mixtures. * Phase 2 was only identified upon prolonged storage (about 3-6 months after sample 
566 preparation). ** Only once has this sample crystallised as Phase 2 in an NMR tube and this sample was 
567 used for SXRD analysis.   
568   
569 Figure 1. A: Photographs of the LID:AZE samples immediately upon grinding. B: POM images of the 
570 solid fusion experiment. C: Interphase at a greater magnification showing dendritic formations. 
571 Figure 2. A: Photographs of the TGA pans after analysis. B: TGA degradation profiles of LID, AZE and 
572 freshly ground binary mixtures. C: Values of % weight loss of LID, AZE and freshly ground binary 
573 mixtures upon heating up to 120 and 200 °C.
26
574 Figure 3. A - First heating DSC thermograms of the samples prepared at room temperature; B – 
575 additional first heating DSC thermograms of the samples prepared at 4 °C. The red dotted line 
576 indicates a sample prepared at room temperature and cooled at 4 °C. 
577 Figure 4. Thermodynamic phase diagram, where Tm of Phase 1 (cocrystal) were obtained from samples 
578 prepared at room temperature, while Tm of Phase 2 (ionic liquid) were obtained from samples 
579 prepared at 4 °C. Dashed lines represent theoretical Schroeder van Laar solubility lines. Black dotted 
580 lines indicate theoretical eutectic composition and Tm. Open star symbols indicate Tg values of the 
581 samples that have undergone crystallisation on cooling. 
582 Figure 5. A: FTIR spectra of the LID:AZE systems at various molar compositions. B: Inset with magnified 
583 carbonyl region of the LID:AZE systems. 
584 Figure 6. A stack of PXRD traces at the range of LID molar fractions χLID. The pattern highlighted in red 
585 corresponds to Phase 1 and the pattern highlighted in orange corresponds to Phase 2. 
586 Figure 7. A: Primary hydrogen bonding motif (dotted lines) in the 2:1 LID:AZE cocrystal (Phase 1). 
587 Displacement shown at 50% probability. Only hydrogen atoms involved in the H-bonding motif are 
588 shown. B: Packing diagram of 2:1 LID:AZE viewed normal to the a-axis. Dotted lines indicate hydrogen 
589 bonding interactions. Displacement shown at 50% probability.
590 Figure 8. A: Primary hydrogen bonding motif (dotted lines) in the 2:3 LID:AZE IL (Phase 2). 
591 Displacement shown at 50% probability. Only hydrogen atoms involved in the H-bonding motif are 
592 shown. B: Packing diagram of 2:3 LID:AZE viewed normal to the a-axis. Dotted lines indicate hydrogen 
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631 Figure 7. 
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637  First oligomeric ionic liquids made of lidocaine and a dicarboxylic acid was synthesised
638  The composition of this ionic liquid was 2:3 lidocaine:azelaic acid
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